Outset Medical

Outset Medical is a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis market.

Outset Medical is a pioneering medical technology company reimagining dialysis for patients and providers.

Outset Medical was founded in 2010 and is headquartered in San Jose, California.

Outset Medical is dedicated to technology-driven service model innovation aimed at reducing cost and transforming the patient care experience.

Outset’s Tablo System is FDA-cleared for use in acute and chronic care settings. In addition to its acute and chronic care commercial expansion, the company has concluded a clinical trial to expand Tablo’s labeled indication to include home use.

 

Outset Medical's human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiencies for providers.

 

Outset Medical is backed by D1 Capital Partners, T. Rowe Price Associates, Fidelity Management and Research Company, Partner Fund Management, Perceptive Advisors and others. The company raised $125M in a Series E financing on Feb 04, 2020. This brings Outset Medical's total funding to $447.3M to date.

 

 

  • Year founded: 2010
  • Funding Info: $447.3M over 7 Rounds (Latest Funding Type: Series E)
  • Yearly Revenue: NA
  • Employee Size: 201-500
  • Business Valuation: NA
  • City/Town: San Jose
  • State: California
  • Country: United States
Related businesses